Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/42213
Title: Imidazole-modified deferasirox encapsulated polymeric micelles as pH-responsive iron-chelating nanocarrier for cancer chemotherapy
Authors: Man Theerasilp
Punlop Chalermpanapun
Kanyawan Ponlamuangdee
Dusita Sukvanitvichai
Norased Nasongkla
Mahidol University
Keywords: Chemical Engineering;Chemistry
Issue Date: 1-Jan-2017
Citation: RSC Advances. Vol.7, No.18 (2017), 11158-11169
Abstract: © The Royal Society of Chemistry. Deferasirox (Def) is an iron-chelating drug used to reduce iron overload in β-thalassemia patients. After the discovery of its tumor growth inhibition, this drug gained tremendous attention in cancer chemotherapy. Herein, deferasirox and its derivatives including methoxy (mDef) and imidazole-modified (iDef) deferasirox were encapsulated in polymeric micelles. Results showed that the release of deferasirox from polymeric micelles was faster at pH 7.4 (physiological condition) than at pH 4.5 (lysosomal condition). However, the release of mDef was pH-independent where both Def and mDef are not suitable for in vivo applications. Therefore, iDef was synthesized to change the pKa from 3.7 (carbonyl group of Def) to 6.8 (imidazole group of iDef) without interfering the iron-chelating efficacy. Interestingly, the release rate of imidazole-modified deferasirox was conversed from that of deferasirox where it exhibited slow release at physiological condition and faster release at the lysosomal condition. This release profile showed a pH-response and an ON-OFF release behavior where iDef is encapsulated in micelles during systemic circulation and released inside cancer cells after intracellular endosomes/lysosome. Cytotoxicity of deferasirox and modified deferasirox were also investigated, and it was found that the IC50 against PC-3 and HepG2 cell lines were in the range of micromolar to submicromolar. Flow cytometry analysis confirmed a decrease in the amount of iron inside lysosome when cells were treated by iDef-loaded micelles. Therefore, iDef-loaded micelles have potential application in cancer treatment as a pH-responsive iron-chelating nanocarrier.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85013102445&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/42213
ISSN: 20462069
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.